Yang Hongzhi, Qin Qiujian, Tang Yulin, Zhu Wenliang
Department of General Surgery, Minzu Hospital of Guangxi Zhuang Autonomous Region, No 232 Mingxiudong Road, Nanning 531200, China.
General Surgery, People's Hospital of Laibin, No 159 PanGu Road, Laibin, Guangxi, 546100, China.
Heliyon. 2024 Jan 8;10(2):e24088. doi: 10.1016/j.heliyon.2024.e24088. eCollection 2024 Jan 30.
Malignant biliary obstruction (MBO) is common in patients with advanced malignant tumors, leading to poor prognosis and hindering antitumor therapy. The purpose of our study was to assess the survival outcomes for patients under therapy after percutaneous transhepatic biliary drainage (PTBD) and identify prognostic factors associated with survival in patients with MBO.
From July 2010 to February 2021, 269 patients with MBO secondary to malignant tumor were divided into two groups (functional success and non-functional success). Survival time and prognostic factors were analyzed by Kaplan-Meier curves and the Cox model.
The overall median survival time after PTBD was 4.6 months (95 % IC:3.9-5.3). The 3- and 6-month survival rates were 68.0 % and 38.7 %, respectively. The median survival improved from 3.2 months to 8.4 months when the procedure achieved functional success. Multivariate analysis demonstrated that functionally successful drainage and antitumor treatment after PTBD were independent positive prognostic factors, but the total bilirubin after drainage and tumor size were independent negative predictive values.
Functionally successful drainage could prolong survival time in patients with malignant biliary obstruction. Palliative care after drainage can prolong patient survival and improve their quality of life.
恶性胆管梗阻(MBO)在晚期恶性肿瘤患者中很常见,导致预后不良并阻碍抗肿瘤治疗。我们研究的目的是评估经皮经肝胆道引流(PTBD)治疗后患者的生存结局,并确定与MBO患者生存相关的预后因素。
2010年7月至2021年2月,269例继发于恶性肿瘤的MBO患者被分为两组(功能成功组和功能未成功组)。通过Kaplan-Meier曲线和Cox模型分析生存时间和预后因素。
PTBD后的总体中位生存时间为4.6个月(95%置信区间:3.9 - 5.3)。3个月和6个月的生存率分别为68.0%和38.7%。当该操作取得功能成功时,中位生存时间从3.2个月提高到8.4个月。多因素分析表明,PTBD后功能成功的引流和抗肿瘤治疗是独立的阳性预后因素,但引流后的总胆红素和肿瘤大小是独立的阴性预测指标。
功能成功的引流可延长恶性胆管梗阻患者的生存时间。引流后的姑息治疗可延长患者生存期并改善其生活质量。